The interactive APV workshop will highlight Advanced Therapy Medicinal Products (ATMP) as products in development for market supply. The speakers will share background knowledge gained during strategic planning and pharmaceutical development of designated orphan and non-orphan drugs.
The workshop places a strong emphasis on active dialogue between participants and speakers. Members of the APV focus group “Pharmaceutical Biotechnology” will also be present on-site to support professional exchange.
The event combines in-depth knowledge transfer to support market access of ATMP with targeted discussion of specific questions related to individual product portfolios.
Part of the workshop will be led by Dr. Hans-Georg Eckert, Managing Director and Senior GMP Consultant at Valicare GmbH. As a qualified biologist, he draws on nearly 30 years of professional experience in guiding and implementing GMP compliance.
Did we catch your interest? In the following document you can find all information at a glance as well as the online access. To register, please send the completed form to: info@apv-mainz.de or use this link.
Invitation: APV Workshop ATMP 2025

Our customers are also interested in:
Professional GMP compliance ensures the quality of drugs and active ingredients.
ATMPs offer new, promising therapeutic approaches for diseases that were previously considered incurable. However, the regulatory requirements are challenging.
Valicare is an ISO 9001-certified service company and operates in the area of qualification and validation of technical equipment and processes.